Khaled Nasr, Insider at Trius Therapeutics Inc (TSRX), bought 3,548,643 shares at $5.00 ($9.4M) on 2010-08-06, disclosed to the SEC on 2010-08-10.
Open-market purchase of $9.4M TSRX by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,576,814 | $0 | 0.0% |
| 2 | $4.38 | 744,496 | $3.3M | 34.7% |
| 3 | $5.00 | 1,227,333 | $6.1M | 65.3% |
| Total | $2.65 avg | 3,548,643 | $9.4M | 100% |
| Filing → |
| TSRO | BUY | 2012-07-05 | $6.0M | — | Filing → |